ARCHIVES

House subcommittee’s 5.6% Increase For NIH includes $2.5 Billion for NCI

This article is from The Cancer Letter archive.

Vol. 23 No. 28 | July 18, 1997

Download PDF Visit The Full Archive

Related Articles

Emory’s Winship Cancer Institute Wins NCI Cancer Center Designation

April 17, 2009

ODAC Votes 13:0 For Approving Perjeta

September 27, 2013

FDA To Tighten Up Regulations On Anticancer Drug Combinations, Stop “Permissiveness”

September 3, 1976

Also Von Eschenbach role in industry program raises new concerns of conflict of interest.

November 23, 2005

Retrovirus Vaccination Is Feasible, Workshop Participants Conclude

May 3, 1985

In Brief: David Feigal To Head FDA’s Antiviral Division; ODAC To Discuss Melphalan, Amifostine NDAs

January 17, 1992